Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1.
|
J Biol Chem
|
2004
|
1.67
|
2
|
Microsomal prostaglandin E synthase-1 is a major terminal synthase that is selectively up-regulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-induced arthritis model.
|
J Immunol
|
2003
|
1.35
|
3
|
The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation.
|
Diabetes
|
2009
|
1.32
|
4
|
Prostate cancer risk assessment program: a 10-year update of cancer detection.
|
J Urol
|
2007
|
1.28
|
5
|
Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients.
|
J Am Soc Nephrol
|
2006
|
1.24
|
6
|
An Australian casemix classification for palliative care: lessons and policy implications of a national study.
|
Palliat Med
|
2004
|
1.08
|
7
|
Cardiac magnetic resonance T2 mapping in the monitoring and follow-up of acute cardiac transplant rejection: a pilot study.
|
Circ Cardiovasc Imaging
|
2012
|
1.03
|
8
|
The last drag: an evaluation of an LGBT-specific smoking intervention.
|
J Homosex
|
2012
|
0.99
|
9
|
Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.
|
J Med Chem
|
2011
|
0.97
|
10
|
Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients.
|
J Heart Lung Transplant
|
2005
|
0.97
|
11
|
The development of Version 2 of the AN-SNAP casemix classification system.
|
Aust Health Rev
|
2007
|
0.95
|
12
|
Transport and deposition of sediment-associated Escherichia coli in natural streams.
|
Water Res
|
2005
|
0.94
|
13
|
An Australian casemix classification for palliative care: technical development and results.
|
Palliat Med
|
2004
|
0.93
|
14
|
Pharmacological characterization of a selective COX-2 inhibitor MF-tricyclic, [3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2-(5H)-furanone], in multiple preclinical species.
|
Eur J Pharmacol
|
2007
|
0.92
|
15
|
Clinical specialists and advanced practitioners in physical therapy: a survey of physical therapists and employers of physical therapists in ontario, Canada.
|
Physiother Can
|
2008
|
0.91
|
16
|
Time-dependent clearance of mycophenolic acid in renal transplant recipients.
|
Br J Clin Pharmacol
|
2007
|
0.88
|
17
|
Phase I, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus.
|
Arthritis Rheum
|
2013
|
0.86
|
18
|
Synthesis and SAR of pyrimidine-based, non-nucleotide P2Y14 receptor antagonists.
|
Bioorg Med Chem Lett
|
2011
|
0.85
|
19
|
Comparison between two classes of selective EP(3) antagonists and their biological activities.
|
Bioorg Med Chem Lett
|
2006
|
0.85
|
20
|
Health services research and development in practice: an Australian experience.
|
J Health Serv Res Policy
|
2003
|
0.85
|
21
|
Complex HeartMate II infection treated with pump exchange to HeartWare HVAD.
|
ASAIO J
|
2013
|
0.85
|
22
|
Traumatic shoulder injuries: a force mechanism analysis-glenohumeral dislocation and instability.
|
AJR Am J Roentgenol
|
2013
|
0.84
|
23
|
Structure-activity relationship studies on ortho-substituted cinnamic acids, a new class of selective EP(3) antagonists.
|
Bioorg Med Chem Lett
|
2005
|
0.84
|
24
|
Biological activity and preclinical efficacy of azetidinyl pyridazines as potent systemically-distributed stearoyl-CoA desaturase inhibitors.
|
Bioorg Med Chem Lett
|
2010
|
0.83
|
25
|
Characterization of platelet-derived growth factor-C (PDGF-C): expression in normal and tumor cells, biological activity and chromosomal localization.
|
Int J Biochem Cell Biol
|
2002
|
0.83
|
26
|
Weekly bryostatin-1 in metastatic renal cell carcinoma: a phase II study.
|
Clin Cancer Res
|
2003
|
0.81
|
27
|
Improving operating theatre communication between the orthopaedics surgeon and radiographer.
|
ANZ J Surg
|
2013
|
0.78
|
28
|
Pyridazinones as selective cyclooxygenase-2 inhibitors.
|
Bioorg Med Chem Lett
|
2003
|
0.78
|
29
|
3,4-Diaryl-5-hydroxyfuranones: highly selective inhibitors of cyclooxygenase-2 with aqueous solubility.
|
Bioorg Med Chem Lett
|
2003
|
0.78
|
30
|
Findings From the National Machine Guarding Program: A Small Business Intervention: Lockout/Tagout.
|
J Occup Environ Med
|
2016
|
0.77
|
31
|
The development of potent non-peptidic PTP-1B inhibitors.
|
Bioorg Med Chem Lett
|
2004
|
0.76
|
32
|
Guidelines for the practice and performance of manipulation under anesthesia.
|
Chiropr Man Therap
|
2014
|
0.75
|
33
|
Findings From the National Machine Guarding Program-A Small Business Intervention: Machine Safety.
|
J Occup Environ Med
|
2016
|
0.75
|
34
|
Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial.
|
Transplantation
|
2017
|
0.75
|
35
|
The right to refuse treatment: Commonwealth developments and issues.
|
Int J Law Psychiatry
|
1983
|
0.75
|
36
|
Sense and Sensibility When Prescribing 'Off-Label' to Psychiatric Patients.
|
Curr Pharm Des
|
2015
|
0.75
|
37
|
Traumatic shoulder injuries: a force mechanism analysis of complex injuries to the shoulder girdle and proximal humerus.
|
AJR Am J Roentgenol
|
2013
|
0.75
|
38
|
Findings From the National Machine Guarding Program: Safety Climate, Hazard Assessment, and Safety Leadership in Small Metal Fabrication Businesses.
|
J Occup Environ Med
|
2017
|
0.75
|
39
|
Hemolysis and pump failure secondary to spontaneous bend relief disconnection in a HeartMate II device with a sealed outlet graft.
|
J Heart Lung Transplant
|
2012
|
0.75
|
40
|
Bacterial Pathogen Indicator Transport from Livestock Mortality Biopiles.
|
J Environ Qual
|
2015
|
0.75
|
41
|
Assessment of denitrification gaseous end-products in the soil profile under two water table management practices using repeated measures analysis.
|
J Environ Qual
|
2005
|
0.75
|
42
|
Discovery of a potent and selective COX-2 inhibitor in the alkoxy lactone series with optimized metabolic profile.
|
Bioorg Med Chem Lett
|
2002
|
0.75
|
43
|
Modeling E.coli fate and transport in treatment wetlands using the water quality analysis and simulation program.
|
J Environ Sci Health A Tox Hazard Subst Environ Eng
|
2011
|
0.75
|
44
|
Platelet-Rich Growth Factor for Lip and Perioral Rejuvenation. A Case Study on "The Kiss Shot".
|
Dent Today
|
2016
|
0.75
|